PlainRecalls
FDA Drug Low Class III Terminated

Clonazepam Tablets, USP, 1.0 mg, packaged in a 100- count unit dose box of 10 x 10 blister cards, Rx only, Manufactured by Mylan Pharmaceuticals Inc, Morgantown, WV, 26505, NDC 51079-882-20

Reported: November 16, 2016 Initiated: September 28, 2016 #D-0136-2017

Product Description

Clonazepam Tablets, USP, 1.0 mg, packaged in a 100- count unit dose box of 10 x 10 blister cards, Rx only, Manufactured by Mylan Pharmaceuticals Inc, Morgantown, WV, 26505, NDC 51079-882-20

Reason for Recall

Failed Impurities/Degradation Specifications: out of specification result for Clonazepam Related Compound (RC) A (a known impurity) at 16 month timepoint.

Details

Units Affected
46,472 unit dose blister cards (10 cards of 10 tablets each)
Distribution
Nationwide
Location
Rockford, IL

Frequently Asked Questions

What product was recalled?
Clonazepam Tablets, USP, 1.0 mg, packaged in a 100- count unit dose box of 10 x 10 blister cards, Rx only, Manufactured by Mylan Pharmaceuticals Inc, Morgantown, WV, 26505, NDC 51079-882-20. Recalled by Mylan Institutional, Inc. (d.b.a. UDL Laboratories). Units affected: 46,472 unit dose blister cards (10 cards of 10 tablets each).
Why was this product recalled?
Failed Impurities/Degradation Specifications: out of specification result for Clonazepam Related Compound (RC) A (a known impurity) at 16 month timepoint.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 16, 2016. Severity: Low. Recall number: D-0136-2017.